View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Norbrook is expanding its NSAID range with the launch of Loxicom Injection for cattle, pigs and horses.
Norbrook says the new product, which will be available to veterinary surgeons from mid-October, offers treatment for a range of symptoms including pneumonia, acute mastitis and calf scour in cattle, swine locomotor diseases such as lameness and MMA syndrome, acute and chronic musculo-skeletal disorders and equine colic.
Rebecca Pullon, Norbrook Product Manager said: "Loxicom is our tried and trusted NSAID range which has been available in suspension or injection for cats and dogs and which has proven exceptionally popular with veterinary practices. According to the GFK data, Norbrook is the most successful generic manufacturer of Meloxicam, by some distance.
"I am delighted that we can now extend this range to include a Loxicom Injection for Cattle, Pigs and Horses, which I am confident will prove equally as popular."
"As a bio-equivalent product, Loxicom Injection for cattle, pigs and horses is as effective as the pioneer product. There is a misperception that a bioequivalent product is somehow inferior to the pioneer product, which is untrue. In order to attain a license, a company must prove that a bio-equivalent product is at least as effective as the pioneer. With Loxicom Injection for cattle, pigs and horses, it comes with the added reassurance that it has been produced by Norbrook, a world leader in animal health and veterinary pharmaceuticals manufacture."
Registered VN Lindsay Newell has been found guilty of six counts of cruelty to animals at Stafford Magistrates' Court, following an investigation by the RSPCA.
The charges related to a ewe, two lambs, a Welsh pony, a goat and a pig at the Burton Wildlife and Animal Rescue Centre, a sanctuary founded in 2008 by the 27-year-old nurse in memory of her murdered grandparents.
The pig had made headlines in the Daily Mail in 2012 when Newell rescued it from a Derby council house.
Newell was given a 2-year conditional discharge, ordered to pay £2000 in costs, and disqualified from keeping sheep, equines, goats or pigs for five years.
Passing sentence, district judge David Taylor said: "These were not deliberate or intentional acts. They were a consequence of you trying to take on too many animals of a wide range."
Newell was cleared of 25 other charges of failing to feed the animals in her care properly.
RSPCA inspector Jayne Bashford who led the investigation said: "We are satisfied that the court has found the defendant guilty of six charges of unnecessary suffering. The scene the RSPCA discovered when they visited with Police, Derbyshire Trading Standards and an independent vet were quite shocking.
"This was an extremely disturbing case where there was clear neglect and mistreatment of animals by a registered veterinary nurse.
"I am sure she set up this centre with the best intentions but things got totally out of control."
More on this story
The new app, which is being being made available in the run up to Pet Diabetes Month in November, allows owners to track water and food consumption, exercise, glucose levels and insulin injections on their smartphone or tablet. It can also send reminders for veterinary appointments and insulin injections, and creates charts that clients can share with their veterinary surgeon.
MSD says the Pet Diabetes Tracker will help improve client reporting and compliance, resulting in improved pet welfare and a reduction in risk to pets through its alert system.
Caroline Darouj, Product Manager at MSD Animal Health said: "To help ensure the long-term health and well-being of a pet, successfully managing the various facets of the disease and treatments is critical.
"With proper management and monitoring a dog or cat with diabetes can lead a healthy, happy and active life, and the Pet Diabetes Tracker can help make it happen. This is an incredibly useful tool that links the pet owner with the vet and puts all the pertinent diabetic health information at their fingertips. It’s all about setting habits that save lives!"
The Pet Diabetes Tracker can be downloaded from iTunes, here: https://itunes.apple.com/uk/app/pet-diabetes-tracker-uk/id1284472796?ls=1&mt=8.
MSD says an Android version will also be available soon.
For more information, visit www.petdiabetesmonth.co.uk or contact your MSD Animal Health account manager.
The new service was reported in The Times, in an article titled "How much should your vet cost? Pet owners bitten by untamed fees."
Since launch, VetHelpDirect has offered owners information to help them pick a veterinary practice, including reviews, ratings (including a value for money score), RCVS accreditation, cat/ rabbit friendly status, health plan details and how out of hours cover is provided.
It has now added some basic information about each practices' charges, specifically the first consultation fee, a dog castrate and health plans, and then categorised them according with £££££ signs to indicate how far above or below the average they sit.
Susie Samuel said: “Most practices will give out these prices over the telephone, but there’s no way for the client to find them without directly getting in touch, something people are less and less likely to want to do nowadays.
"Our research data suggests that people want to find this information online, just as they would in any other service industry.
"When they can’t find any information at all on pricing, there can be a perception of secrecy that can do damage to the vet-owner relationship.”
Susie added: “True comparison for vet practices is of course very complex and no basket of services is ever going to capture the whole complexity.
"Every practice is different, from facilities and team qualifications; to the time allotted for consultations; to monitoring equipment for surgery; and of course the level of investigations undertaken which can also vary from vet to vet.”
“We can’t solve all this straight away but we started from a good place, over the years we have built up more information about vet practices than any other website.
"The aim is to provide commonly requested prices for owners to easily access and to add more and more detail on the vet practices over time so that owners can make the most informed choice on the vet that's most appropriate for them and their pet”.
VetHelpDirect says it will soon be adding prescription fees and out of hours consultation, and a much wider range of species-specific fees in the near future.
The company also points to the Competition and Markets Authority investigation into pricing in the UK, highlighting that in its 2019 Report into Funerals in the UK, the CMA noted that weaknesses in the sector included the fact that less than 40% of funeral directors posted any form of pricing online, and those that did were frequently not in a form that made for easy comparison.
Susie says the veterinary sector has an even lower rate of online pricing transparency.
To add your pricing information to VetHelpDirect, email: info@vethelpdirect.com.
COMMENT
Whilst greater transparency over pricing in almost any field is surely to be welcomed, it seems questionable whether comparing prices for consultations and standard procedures will be of much help to pet owners, because things like the level of investigations, how defensively a clinician practises and the owner's own relationship with risk are likely to have a far greater impact on the bill than whether a consult costs £20 more or less up the road.
There is perhaps also a risk of practices rated as '£££££ / more expensive than average' will be seen as just that. Expensive and nothing more.
It's not like a restaurant where £££££ usually means particularly delicious.
Whilst this may not matter much whilst so many practices are having to turn away business, it may become more important in the future.
Discuss here.
The first two episodes, which discuss feline cardiomyopathy, are available now at: https://www.buzzsprout.com/2189360 and all the leading podcast platforms (including Apple, Spotify, Amazon and Google).
Future topics will include pre-clinical feline cardiomyopathy and a practical approach to puppy murmurs.
There'll also be a number of special guests, including Prof Virginia Luis Fuentes from the Royal Veterinary College, who will discuss the treatment of feline heart disease beyond standard therapy, and Dr Brian Scansen from Colorado State University, who will talk you through the diagnosis and management of pulmonic stenosis.
To keep up with the latest from Kieran and Jose, you can follow them on Twitter or Instagram @heartbeat_pod.
They'd also love you to post to questions for their guests, or any comments you have about the podcasts, on their social media channels.
Jonathan will be taking part in the VETFest Conversation on the Friday evening: a relaxed conversation with event founder Professor Noel Fitzpatrick in an intimate setting which organisers say allows delegates to really feel and be part of the conversation.
Noel and Jonathan will be reflecting on some of the common experiences, fears and thoughts all people from all walks of life share.
Noel said: "We are so excited that Jonathan has agreed to join us for the official launch of the VETFest Conversation on Friday night. Jonathan will offer an illuminating new perspective on some of the matters we will all relate to professionally and personally. This is so much more meaningful than just a chat between two people. We want everyone present to feel part of the conversation and converse together as openly and comfortably as is we were in your living room. This is what the VETFest Conversation is about, a really special experience.
"VET Festival has always and will forever be about providing a dynamic and engaging event that empowers all veterinary professionals who attend to leave the field with not only educational development but deep personal enrichment too. We all feel the stresses and strains of failure, financial stress, management challenges, difficult interpersonal relationships, self-confidence, fear and even depression. We lose our connectedness to each other with the weight of these burdens.
"This conference isn’t just about Veterinary Education for Tomorrow – it’s about looking after each other. With the VETFest Conversation, we are aiming for something new; something that depends entirely on raw emotion, passion, knowledge and willingness to share. We want to be the best we can be, together in the open air surrounded by kindness and collegiality.
"Together we hope to entertain and inform, and in doing so join together with everyone present not only as a profession but as a global community. If you are struggling, professionally and/or personally, we want to reach out a hand and reassure you that you are not alone – we are all in this together.
"Whether you are a vet, a nurse, a rehab professional or a TV presenter, we share fears and disappointments as well as joy and fulfilment. Our motivation is to collectively become a positive force for good, so that every one of us, our friends and family, our work colleagues, our businesses, our profession and even our world may benefit.
"There is nothing out there like this – and we want to lead the way in setting the agenda that this really does matter and create a lasting and meaningful community of compassion."
The VETFest Conversation is open to all delegates at VET Festival and takes place after the clinical programme on Friday 8th June at 6.00pm – 6.45pm.
VET Festival tickets are available to buy on Eventbrite: https://www.eventbrite.co.uk/e/vet-festival-2018-tickets-35876825551
Hill's Pet Nutrition has enhanced its portfolio of prescription diets for the management of FLUTD with the launch of Feline c/d Multicare Reduced Calorie and a 'taste upgrade' for Feline c/d Multicare.
Prescription Diet Feline c/d Multicare Reduced Calorie is a new dry product designed to manage the higher incidence of FLUTD in overweight cats (FLUTD is 49% more prevalent in overweight and obese cats2). According to Hill's, the controlled fat and calorie levels in c/d Multicare Reduced Calorie and clinically proven levels of L-carnitine help to reduce fat build up and maintain lean muscles mass. Like c/d Multicare, its formula also dissolves sterile struvite uroliths in 14 days1.
Hill's says Prescription Diet c/d Multicare Reduced Calorie is formulated with omega-3 fatty acids to reduce the distress and discomfort associated with conditions such as FIC (Feline Idiopathic Cystitis); in addition obesity has been associated with systemic inflammation3 for which omega-3 fatty acids are beneficial4,5.
Prescription Diet Feline c/d Multicare Chicken dry kibble has had its taste improved; Hill's says studies show it is now preferred over the leading competitor's brand by a wide margin6. Apparently, the improvement in flavour is partly down to the new shape of the kibble.
Lastly, Hill's is highlighting a prospective study by MacLeay et al, the preliminary results of which were reported at the American College of Veterinary Internal Medicine Forum in May 2010. In the study, cats with uroliths suspected to be struvite (based on radiographic appearance) were fed Prescription Diet Feline c/d Multicare and rapid dissolution of the stones occurred in as little as two weeks.
References
The study, titled “Development and progression of proteinuria in dogs treated with masitinib for neoplasia: 28 cases (2010 – 2019)”, also suggests that a urine protein: creatinine greater than 0.5 should prompt reassessment within one week.
For the study, the clinical records of 38 dogs referred to a single university teaching hospital between 2010 and 2019 for treatment of neoplasia with masitinib were retrospectively evaluated.
Data was collected at masitinib initiation and at various timepoints following the start of treatment.
Data gathered included the masitinib dose given and any changes to medication administration or dosing since the previous visit, presence of gross disease and the results of haematology and biochemistry profiles, urinalysis and urine cultures.
Urinalysis results were only included if they were performed at a reference laboratory.
At each timepoint, the urine was classified as non-proteinuric (UP:C ≤0.5) or proteinurinc (UP:C >0.5). Proteinuria was then categorised as likely pre-renal, post-renal, physiological renal or pathological renal.
Dogs were grouped based on the presence or absence of proteinuria at baseline. Non-proteinuric dogs were further divided, based on whether proteinuria developed following treatment during the study.
Of the 28 dogs in the study, five were being treated for epitheliotropic lymphoma, one for vulval lymphoma, one for malignant melanoma and 21 for mast cell tumours.
Twenty-two (79%) dogs were non-proteinuric and six were proteinuric at baseline.
Of the dogs that were non-proteinuric at baseline, four (18.2%) developed proteinuria within one month of treatment initiation. Median time to first detection of proteinuria was 14.5 days (range: 13 to 31).
Of the dogs with pre-treatment proteinuria (n=6), masitinib treatment was discontinued due to lack of efficacy in three dogs, and three were euthanased during treatment, two for disease progression and one for an unknown reason.
Dr Margaux Kuijlaars, corresponding author for the paper, said: “Patients developing proteinuria should be investigated to exclude non-renal causes. This should allow for more informed recommendations on the monitoring and management of proteinuria and further masitinib treatment in these patients to be made. Masitinib treatment can be considered in patients with pre-treatment proteinuria and does not inevitably cause worsening of proteinuria.
“The findings of this study add to the evidence base for the use of masitinib in treating neoplasia in small animal patients. The use of masitinib in dogs in this study was off-licence as C-KIT MCT expression was not determined, and many dogs were treated for other tumours.”
Nicola Di Girolamo, Editor of JSAP, said: “Little is known about which dogs are predisposed to becoming proteinuric following treatment with masitinib for neoplasia. Due to the small number of dogs in this study that developed proteinuria, conclusions about predisposing factors cannot be definitely drawn.
"The findings of this study add to the evidence base and demonstrate the need for larger, prospective trials including a control population and longer period of follow-up.”
The full article can be found in the August issue of the Journal of Small Animal Practice and can be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13305. It is open access and can be freely accessed by anyone.
Reference
Norbook has added a 200ml oral suspension for dogs to its Loxicom range.The company says the new presentation provides a cost-effective way to supply long-term dosing for pain management in dogs. It also says the new size will allow vets to be more efficient with stock space and animal owners will save money with less frequent repeat purchases.
Norbook veterinary advisor Rebekah Dudek said: "With winter upon us, the colder weather can cause symptoms of arthritis to worsen. With over 20% of dogs, 50% of adult cats and 60% of horses affected by arthritis now is the time to find out why so many vets are choosing Loxicom as their choice for pain management.
"This extension to the popular Loxicom range allows vets the opportunity to offer users a range of options when dispensing pain relief medication. The 200ml bottle is a cost-effective solution for long term treatment which will please both vets and pet owners."
For more information, visit: www.norbrook.com.
GRAM (Guidance for the Rational use of AntiMicrobials) is a 500-page guide written by a panel of 10 independent European experts from the fields of microbiology, pharmacology and dermatology, all of whom are specialists in internal medicine, surgery and epidemiology. Based on rational use with compliance at the forefront, GRAM provides tools for improved diagnosis and positive treatment outcomes.
The guide consists of 37 disease fact sheets, 29 practical recommendations and six reference synopses. It features a range of topics including:
Andy Forsyth, senior technical veterinary advisor at Ceva said: "Antimicrobial resistance continues to be a concern in both human and animal health. GRAM will help educate veterinary professionals on how they can play their part in creating sustainable antibiotic use."
To request a copy of GRAM or for further information on sustainable antibiotic use, contact your local Ceva Animal Health territory manager.
French veterinary surgeons went on strike yesterday, and 10,000 marched on the streets of Paris in protest at Government plans to restrict their ability to supply certain farm animal antibiotics.
According to the National Union of Practicing Veterinarians (SNVEL), French veterinary surgeons saw the Government plans as an attack on their integrity and competence, and called for the strike, the first of its kind in history.
As a result of the strike, French Ministers have apparently pledged to retract their plans, something which was welcomed by veterinary representatives at the end of the march to the Ministry of Health (see right; click to enlarge).
At the same time, the SNVEL organised a 'Day Without Veterinarians' in all the French Departments. Given that there are only 11,000 practicing vets in France, 10,000 of whom were in Paris, that bit can't have been a particularly difficult logistical challenge.
Elanco says OA is a condition which is estimated to affect one in four dogs, but it is often labelled by owners as "just old age". This, says the company, may lead to missed diagnosis and dogs not receiving the care they need.
To try and help address the issue, Elanco has partnered with the founder of Canine Arthritis Management, Hannah Capon and veterinary communications consultant, Zoe Belshaw to produce a number of online and in-practice tools.
The first of these is a worksheet to help veterinary surgeons explain the impact of OE on the client's dog, both in and outside the home. It provides a template for creating a tailored management plan and a guide to the home adaptations owners can make to help improve their dog's quality of life.
The company has also produced a infographic fact sheet which explains the subtle signs of OA, designed for vets and nurses to use as part of their regular interactions with owners.
Elanco has also designed a range of digital materials for veterinary practices to use on their websites and social media feeds to increase awareness of the condition among their online communities.
Hannah Capon said: "Arthritis affects every dog differently – a dog may be full of life but lame, quiet, unenthused and slow to move, or somewhere in-between.
"Home management needs to be tailored to each dog’s needs and adapted in the same way it would be for a person, to prolong life and minimise pain and further injury."
Lastly, Elanco has also produced a film in which Zoe Belshaw gives advice about the language and strategies veterinary surgeons can use to help improve communication with dog owners about OA.
Zoe said: "My research identified that many owners do recognise their arthritic dog has a problem before it’s diagnosed. Many will have seen that their dog is stiff, or ‘slowing down’ but they may not associate this with lameness, or pain.
"That’s why vets, nurses and practices play a critical role in raising awareness of how the condition impacts dogs every day."
To access the suite of assets visit: www.myelanco.co.uk
Discospondylitis describes the infection of an intervertebral disc and its adjacent cartilaginous end plates and vertebral bodies.
It is commonly bacterial or fungal in origin.
The disease can be challenging to diagnose as signs are variable and sometimes vague.
For the research, neurology specialists retrospectively examined cases which presented at multiple referral sites that have furthered the understanding, clinical and imaging features of discospondylitis.
To date MRI has been the imaging modality of choice, with consistent CT imaging features of discospondylitis in dogs and cats not previously reported in detail.
However with the increased availability of CT in clinical practice, the research set out to examine CT features that could support a diagnosis of discospondylitis.
Discospondylitis in cats is uncommon, and very little research had been undertaken in this area. This research group therefore reported clinical presentation and imaging data about a population of cats, to support the future diagnosis of these cases.
During the three studies*, the researchers found that:
The studies
The technology, developed by US firm SignalPET, sends X-rays through an AI machine algorithm to get a more or less instantaneous report, rather than needing a radiology specialist to analyse results, which can take up to three days.
IVC starting trialling the system with 22 of its practices last November and it quickly became clear that there were huge benefits, including saving time for clinicians, cost, and improving confidence in the diagnosis.
The majority of IVC's trial teams said they viewed the technology as a positive diagnostic aid, supporting their own professional opinion.
It also served as a learning tool, increasing the confidence and clinical independence of younger or newly qualified vets.
Sarah Merrell, Clinical Director at Lincvet, a group of IVC Evidensia practices in Lincoln and one of the trial clinics, said: “SignalPET has proved really valuable – giving us excellent support for radiography.
"It has been used by both our highly experienced and newly graduated clinicians to get a second set of ‘eyes’ on our cases giving reassurance and support when reading our radiographs.
“Overall, it has improved clinician confidence, reduced the pressure on senior vets, given us an additional tool for training and development, and greatly enhanced client understanding of our findings.”
Alistair Cliff, IVC Evidensia’s Deputy Chief Medical Officer, said: “The AI radiology process developed by SignalPET represents a real revolution in how results are analysed.
"The overwhelming success of our initial trial in November means we are confident in pushing ahead with rolling out the technology in the UK this year and eventually, in Europe too."
The company said:"The RSA Referral Vet Network has been established to give customers access to a trusted network of vets that provide a high standard of service and value for money. However we do understand that in some cases where the primary vet recommends a referral practice and circumstances dictate that our nearest Network partner is not suitable, we will allow our customers to make a choice without being penalised.
If the treatment in question is covered under the policy, there will be no additional fee charged whether or not they choose to use a Network practice."
Vets For Choice, a group of referral practices campaigning against RSA's Preferred Referral Network, welcomed the news.
However other brands, such as MoreThan, Tesco and Argos, have proceeded with the penalty.
Clive Elwood, one of the referral practitioners behind Vets For Choice, said: "The big question to ask now is if John Lewis can opt out of the fines why can’t Tesco and Argos?
"John Lewis clearly does not agree with springing extra charges on their customers at the point of need and this seems to be in line with their reputation for better customer service.
"MoreThan, Tesco and Argos customers should rightly ask why they are being treated differently to John Lewis customers."
In a press release, Vets For Choice highlighted RSA's July announcement that it was extending its then 29-practice strong referral network by 24, noting that only weeks later it announced its group operating profit was up 20% to £312 million.
In a robust response, an RSA spokesperson said: "The handful of vets behind Vets for Choice have point blank refused to discuss the real issue with non-emergency referrals - the huge variation in costs being charged to pet owners by some vets and paid for by insurers. Vets for Choice has refused to address this issue with us either directly or indirectly, and their desire remains to have a complete lack of transparency about their costs and charges. We are no longer prepared to duck the issue of cost and the lack of transparency in vets’ charges. This impacts on pet owners and means their cover limits do not go as far as they should.
"Our network partners recognise that for pet insurance to remain affordable, the veterinary and insurance industry needs to work more closely together on behalf of customers. Vets for Choice are happy to discuss any issue but the real one and they continue to knowingly distort the facts. The reality is that we have now had 12,700 referral claims from our Network partners, with only 79 customers choosing to pay the £200 charge to use a non-Network partner – well under one percent of all customers. The reality is there is no huge public outcry. The reality is that we have not seen any rise in complaints. The reality is that is our customers are more than happy to have our Network partners treat their pets, knowing that their cover limits are going further.
"Vets for Choice also mentioned our 20% rise in Group Operating Profit. The key word here is Group – the fact is the majority of our profit was made from our international markets. Group operating profit bears no relation to how our UK pet insurance business performed and it is disingenuous to link the two. It is also disingenuous to imply that all brands should act in the same way as their business models differ according to the customer segment they wish to attract. As ever, the choice remains with the customer."
Speaking at Improve International's OV Conference last week, Dr Wright cited increased pet travel and importation as key risk factors, including the growing number of rescued dogs arriving in the UK from countries in Europe and further afield.
Dr Wright highlighted the Rhipicephalus tick (Rhipicephalus sanguineus) as being a particular cause for concern, as it can transmit Ehrlichia canis, Anaplasma platys, Rickettsias, Babesia vogeli and Hepatozoon.
Dr Wright said that Ehrlichia canis and Anaplasma platys are among the most common tick-borne diseases in imported dogs, particularly those arriving from Eastern and Southern Europe. There were also three cases of Hepatozoon canis in 2018, caused by dogs ingesting Rhipicephalus ticks while grooming.
According to figures from a Bristol University Pet Travel survey, 54.5% of dog travel on the Pet Travel Scheme from the UK is to France with Southern European countries also popular destinations. These are all countries in which Rhipicephalus is present and on the increase. Dr Wright said that the ticks are moving north into Austria, Switzerland, Central France, Romania and Bulgaria.
During the last few months, he has also been alerted to ticks found on dogs coming in from North America, Latin America and Africa. These bring with them the risk of new diseases, including a variety of zoonotic rickettssial pathogens, such as Rickettsia Rickettsii, which causes Rocky Mountain Spotty Fever.
To address this issue Dr Wright urged vets to redouble their efforts on tick prevention. In particular, he recommended tick prevention pre/during and post travel, using products that offer rapid kill and repellency in order to reduce transmission, repellents being especially important in Leishmania infantum and Rhipicephalus-endemic countries.
Dr Wright recommended drilling clients and staff on tick removal and reminding them that finding a tick on a pet is not a failure as no product is 100% reliable and it is easy to miss them in long-haired dogs. He also suggested asking clients to take photos of any ticks they find on their pet while abroad so that their vet will know on their return what pathogens they may have been exposed to. If necessary, the Public Health England Tick Surveillance Scheme can help with identification.
Dr Wright suggested that legislation to enforce tick treatment on entry was a poor strategy used in isolation as pets would still be exposed while abroad and no product is completely reliable. It would be useful however, to raise awareness and show that we are taking the issue of tick-borne disease seriously.
He said: "We’re seeing a significant increase in pet travel and import a wider range of countries from which dogs are being imported and this is significantly increasing our exposure to exotic ticks.
"What’s news about this is that while you could argue that diseases such as Lyme Disease are ‘lifestyle’ diseases because people and dogs are exposed to our native ticks while out enjoying the countryside, the Rhipicephalus tick comes to your home, exposing you to a wealth of rickettsial diseases for the first time. We are already seeing instances of this in France, Germany and Scandinavia and, as pet travel continues to grow, the risk here will only increase. It’s equally possible that a dog with a native tick could travel aboard and return hosting a new pathogen.
"The only way to manage this risk is to provide consistent advice to the public and to support increased disease surveillance. Vigilance is key – assume that any travelling dog may have ticks and do not assume that because it is tick-treated, it’s a case of ‘job done.’"
He said: "Put the onus on clients - gently. Remind them to seek advice, to check for ticks and to keep tick treatments up to date. Also remind them to visit the practice with their dog as soon as possible on their return. If you do find exotic ticks, please send them to the Tick Surveillance Scheme for identification."
He added: "If you know an owner who is planning to adopt a dog from abroad, explain the risks to them and encourage them to adopt from the UK. If they are determined to go ahead, work with them to ensure that you reduce the risk of exotic ticks arriving with their new family members. The risk to human and animal health from an infestation should not be underestimated."
Direct Line made Freedom of Information requests to 44 police forces in the UK, of which 38 were able to provide usable data.
The number of dogs reported stolen in 2017 was 7% up on 2016, which in turn was 14% higher than in 2015.
In second place after Staffies (210 thefts) came crossbreeds (82 thefts), followed by French Bulldogs (61 thefts).
Geographically, the canine crime capital of the UK is, wait for it ... Yorkshire. Eeh by gum.
There were 346 reported dog thefts in Yorkshire and the Humberside, compared to 312 in the North West and 216 in the South East.
If you want to reduce your chances of being the victim of crime by owning the least stolen dog in the safest area, the data suggests you should buy a Springer and go and live in Wales.
Photo: English Staffordshire Bull Terrier, Nieuwland Photography / Shutterstock.
Vetswap was set up by Luke Ramsden and Euan McKee MsRCVS, two globe-trotting veterinary surgeons who saw the opportunity for colleagues in the profession to combine work and travel without losing the security of their long-term job.
As part of the partnership, VetSurgeon Jobs now includes a dedicated section for VetSwap which contains a link to job swap opportunities posted by the company.
VetSurgeon.org Editor Arlo Guthrie said: "Job swapping sounds like a great way to get a fresh-perspective and gain some CPD, not to mention a holiday in the sun.
"VetSwap is a natural fit with VetSurgeon Jobs, broadening the range of opportunities we can offer.
"On top of that, VetSurgeon.org exists to support veterinary surgeons, so when Euan and Luke contacted me, I was only too pleased to do what I can to try and give them a leg up."
VetSwap is now running a competition to win £200 worth of Amazon vouchers and a free VetSwap. All you have to do is visit their Facebook page and share this post with a colleague: https://www.facebook.com/VetSwapTM/videos/1881120178807211/
The UK has now seen a total of 169 confirmed cases of Alabama Rot across 38 counties, since 2012. Six cases were confirmed in 2012, climbing to 40 in 2017 and 46 so far in 2018.
The new research, which was carried out in conjunction with the Royal Veterinary College, found that almost 95% of confirmed cases of Alabama Rot have occurred between November and May, with the highest number of cases being reported in February.
It also found most of the cases have been confirmed in western and southern parts of England, with the highest number found in West Sussex, Dorset, southern Hampshire, Greater Manchester and Monmouthshire. Far fewer cases have been reported from the eastern half of the country and East Anglia in particular.
David Walker, Head of medicine at Anderson Moores and co-author of the research, said: "This research, which was funded by the New Forest Dog Owners Group and the charity Alabama Rot Research Fund, was designed to look for geographical patterns, as well as environmental and climatic risk factors.
"A distinct seasonal pattern is suggested, with the vast majority of cases occurring between November and March, and limited cases over the summer months – just 6.5% of cases have been confirmed from June to October.
"In the scientific world a lot of research is not earth-shattering, but it all builds together and little by little we make progress.
"This information is good in terms of how we manage the next stage of research, however we need to be careful and not jump to any conclusions at this point".
Researchers say the disease has been reported in a wide range of breeds (35 in total) but, due to the small number of cases, it is not yet possible to say with any certainty whether a specific breed has an inherently increased or decreased risk of the disease. Any patterns may simply be the result of varying breed populations in different parts of the country.
Dr Huw Stacey, vet and director of clinical services at Vets4Pets, has been supporting research on the condition for a number of years. He said: "Since we held the first Alabama Rot conference in May 2017, vets and relevant professionals have been working hard to understand more about the condition.
"We know how the disease presents and how it affects dogs internally, and this research adds some interesting information that may help to increase vets’ index of the suspicion for the disease.
"The information on climate and ground type will help us further explore possible triggers for the disease, but at the moment we can’t say if any breeds are more likely to develop the disease.
"The first sign of the disease that is normally seen is a skin sore or lesion that isn’t caused by a known injury. Most commonly these sores are found on the lower half of the leg and appear as a distinct swelling, a patch of red skin or are open and ulcer-like.
"With 46 cases in 2018 already, it is understandably very worrying for dog owners, but we think the increase in cases is partially due to an increased awareness of the disease.
"However, this disease is still very rare, so we’re advising dog owners to remain calm but vigilant, and seek advice from their local vet if their dog develops unexplained skin lesions.
"While this research may be a stepping stone to finding the cause of Alabama Rot, there is currently no known way to prevent a dog from contracting the disease."
*also clinically known as
Two analyses of the pet insurance market have been published this week, which together suggest that veterinary practices may be starting to price themselves out of the market.
Both reports are titled Pet Insurance 2014. In the first, published by Key Note Ltd, authors highlight a 35.4% increase in gross claims incurred on cat and dog insurance policies between 2009 and 2013, which is more than 5 times the increase in the volume of claims over the same period. It is the degree to which the value of claims has outstripped the volume which the report describes as 'undeniably the greatest factor affecting the UK market for pet insurance.
At the same time, there has been a relatively modest growth in the percentage of adults that own a cat or dog (around 1.5 percentage points). Consequently, premiums increased by 38.9% between 2009 and 2013 as insurers responded to the growing cost of claims.
Meanwhile, the other Pet Insurance 2014 report, this time from YouGov, has shown that the main factors limiting the uptake of pet insurance are poor value for money and the high cost of premiums. In 2012, 31% of owners without insurance said it was not good value for money, and that was the main reason for not taking out cover. By 2014, that figure had risen to 39% of the uninsured and 26% said they just cannot afford premiums.
According to the YouGov report, the words that uninsured pet owners most associate with pet insurance are 'expensive' (68%) and 'waste of money' (30%). Even 57% of those with insurance deem it expensive.
YouGov also highlighted that the number of uninsured pet owners who say they can afford to pay for veterinary treatment out of their own pockets (without setting money aside each month) has increased 4 percentage points from 15% in 2012 to 19% in 2014. YouGov hypothesises that this may be down to the improving economic situation in the UK, but it could equally be explained as just the way hard-pushed people self-justify their decision to discontinue insurance.
James McCoy, Research Director, YouGov Reports said: "Although social grade is important to being able to afford to take out pet insurance, our research suggests that those at different ends of the financial spectrum share the opinion that cover is not necessarily always a sound financial option.
"More affluent pet owners find insurance poor value because they can afford to pay for treatment up front; for less affluent pet owners, while pet insurance is perceived as offering good value for money, the cost of premiums is prohibitive, leading some to save money instead."
Rabbits are the third most commonly anaesthetised pet in the UK, however they have a seven times greater overall risk of perioperative death than dogs1.
Jurox says Alfaxan 10mg/ml solution for injection provides a wide safety margin, an excellent cardio-respiratory profile and is dosed to effect, making it an excellent choice for the anaesthetic induction of rabbits.
The company also says Alfaxan provides smooth and rapid induction and recovery, painless administration and good muscle relaxation with low impact on ventilation and blood pressure.
Richard Beckwith, country manager of Jurox (UK) Ltd said: "Rabbits are a growing pet population and increasingly play a more important part in UK vet practices, which is why Jurox has invested in research in this species.
"We are happy we can now support our vet and nurse clients by providing a new and reliable choice for induction of anaesthesia in pet rabbits that has been extensively trialed and researched.
"Alfaxan is a very versatile product as it is convenient for any type of situation, whether it is surgery on healthy animals or high risk patients such as pet rabbits. With Alfaxan we hope to make a contribution to the future of veterinary anaesthesia in the UK and are confident our clients will be able to deliver the best practice anaesthesia they believe in."
For more information, visit: Alfaxan.co.uk. Alternatively, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
'Hany’s Heartbreak' was a gorily realistic representation of a dog’s heart infected with Dirofilaria Immitis, baked by vet students Anna Burrows, Caitlin Glover, Chloe Tredinnick and Liberty Daly.
It pulled in votes from all over the world including Australia and the US, Saudi Arabia, Germany, Italy and the Caribbean.
The winning bakers said: "We chose to bake this cake as we wanted to make something that we could make look as realistic as possible and as gruesome.
"Our parasitology lecturer, Hany, inspired us to use the D. Immitis parasite as our theme to promote the message of how detrimental and possibly fatal some animal parasites can be! We had a great time baking it and enjoyed the looks of disgust that people who saw it gave. We promise it tastes better than it looks! Our key message to everyone is to PLEASE WORM YOUR PETS!"
The categories for baking inspiration this year were Transport to Campus, Scrumptious Science, Blue Planet and a Showstopper section. Sir David Attenborough and Pixar characters Nemo and Dory were among the other stars of the show, with colourful cakes on an environmental theme also winning prizes.
One of this year’s judges was Dr Wendela Wapenaar, Associate Professor at the Nottingham Vet School. Wendela said: “It’s been another great year for the Sutton Bonington Bakeoff. It was impressive to see how some bakers took on the challenging topics for this year; winning cakes were covering topics such as global warming, environmental pollution in addition to the more gory aspects of veterinary medicine."
Vetoquinol has announced the launch of Rubenal®, a new product for use in renal health management for dogs and cats.
Normal kidney function is dependent upon normal nephron and interstitial tissue structure. When the balance of renal health is tipped, this structure can change and fibrous tissue can accumulate.
Simon Boulton, Rubenal®'s product manager said: "Rubenal® is the first palatable veterinary formulation of Rheum officinale available for use in both dogs and cats. It can be used as an aid to the maintenance of the normal renal fibrotic architecture."
The company has also produced a new guide to the management of chronic renal failure in dogs and cats: Chronic Kidney Disease: Addressing quality of life and life expectancy.
Simon said: "Vetoquinol is dedicated to supporting renal health and the guide is designed to illustrate factors which can affect both quality and quantity of life, including hyperphosphataemia, hypertension, proteinuria, azotaemia and fibrosis in renal disease."
The booklet contains guidelines on the appropriate management of these factors including a wall chart reference guide.
For more information about Rubenal, or a free copy of the guide, please contact your Vetoquinol representative or telephone 0800 1698197.
Duoflect contains a new formulation of fipronil and (s)-methoprene which, according to the company, offers a 100% longer duration of action against fleas in cats (eight weeks), and a 13% longer duration in dogs (nine weeks) than the market-leading fipronil combination.
Ceva says the Duoflect's duration of action against ticks is 150% longer in cats (5 weeks) and 50% longer it cats (six weeks) than the market-leading competitor.
Duoflect acts against both adult fleas on the animal and immature flea stages in the environment and it can also be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
Duoflect is available in free-standing pipettes for easier administration and handling of the pet. The pipettes are packed in child-resistant aluminium blisters to reduce the risk of accidents at home.
Nicki Glen, marketing project manager for Duoflect at Ceva Animal Health said: "Recent research1 has revealed that two main factors in prescribing parasitic control products are the length of action and the increased efficacy against fleas.
"Duoflect's new strength formulation provides a longer duration of action than the market-leading fipronil combination, while its efficacy is proven through 13 recent laboratory and field trials1."
Duoflect is competitively priced and is available in boxes of three or six pipettes and in five presentations: small cats (1-5kg), large cats (>5kg) and small dogs (2-10kg) and medium dogs (10-20kg), large dogs (20-40kg) and extra large dogs (40-60kg). It is suitable for cats and dogs from eight weeks of age.
Ceva Animal Health has produced a range of supporting marketing materials including client leaflets.
For more information, contact your local Ceva Animal Health territory manager or call Ceva’s head office on 01494 781510.
In addition to working as a clinician in private practice and for charity, Gudrun has worked in several veterinary-related roles in industry, both in management and as a consultant, as well as being the Chair for the British Veterinary Association’s Good Veterinary Workplace Working Group.
In the new role, Gudrun will work support the implementation of the British Veterinary Association’s Good Veterinary Workplaces Code across the business.
Gudrun said: “Having been heavily involved in the work leading up to the Good Veterinary Workplaces Code during my time at the British Veterinary Association, I can fully relate to the many pressures that veterinary workplaces are currently under.
"Through supportive action and using evidence-based tools, I believe we can make a positive and lasting difference.
“It’s an honour to join Vets4Pets as we begin to implement its many commitments to improving the industry.
"I am excited to work towards a positive future for veterinary workplaces and being able to work with Vets4Pets to build a well-resourced and accessible tool for practices to implement good veterinary workplaces will help our practices to attract and retain the best clinical talent.”